Following Lung Foundation New Zealand’s (LFNZ) participation in the patient group meeting hosted by The Pharmac Review Committee on 16th July in Wellington, we have taken the opportunity to provide a further submission. We so respect this/our very brave patient, for highlighting the terrible inequity lung cancer patients are faced with in NZ. LFNZ has a further meeting with The Pharmac Review Committee on the 3rd November.

October 2021- Lung Foundation NZ submission to Pharmac Review Committee

Lung Foundation New Zealand is an active member of Cancer Non-Government Organisations (CANGO).

Click to view CANGO’s manifesto
1707_CANGO2020